Finoriq research workspace
Adagio Medical Holdings, Inc. (ADGM) Institutional Holdings & 13F Ownership
Adagio Medical Holdings, Inc. offers treatment for cardiac arrhythmias, including atrial. Review ADGM institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
- Company
- Adagio Medical Holdings, Inc. (ADGM)
- Ticker
- ADGM
- Market Cap
- $12M
- Latest Price
- $0.5396
- Industry
- Medical Devices
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.